Altimmune (ALT) had the highest return between February 27, 2020 and March 8, 2020 by a small-cap US stock, returning 124.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Altimmune (ALT) | 2/27/2020 - 3/8/2020 | 124.85% |
Opko Health (OPK) | 2/27/2020 - 3/8/2020 | 64.54% |
Byrna Technologies (BYRN) | 2/27/2020 - 3/8/2020 | 50% |
BioCryst Pharmaceuticals (BCRX) | 2/27/2020 - 3/8/2020 | 44.21% |
Omeros (OMER) | 2/27/2020 - 3/8/2020 | 42.81% |
Ocular Therapeutix (OCUL) | 2/27/2020 - 3/8/2020 | 41.31% |
HIVE Blockchain Technologies (HIVE) | 2/27/2020 - 3/8/2020 | 41.18% |
Tutor Perini (TPC) | 2/27/2020 - 3/8/2020 | 35.02% |
Arcturus Therapeutics (ARCT) | 2/27/2020 - 3/8/2020 | 33.04% |
SunOpta (STKL) | 2/27/2020 - 3/8/2020 | 32.29% |
Q32 Bio (QTTB) | 2/27/2020 - 3/8/2020 | 31.77% |
Arcus Biosciences (RCUS) | 2/27/2020 - 3/8/2020 | 28.53% |
Sangamo Therapeutics (SGMO) | 2/27/2020 - 3/8/2020 | 23.69% |
CRA International (CRAI) | 2/27/2020 - 3/8/2020 | 23.4% |
Castle Biosciences (CSTL) | 2/27/2020 - 3/8/2020 | 23% |
Ooma (OOMA) | 2/27/2020 - 3/8/2020 | 22.47% |
Intellia Therapeutics (NTLA) | 2/27/2020 - 3/8/2020 | 21% |
Ingles Markets (IMKTA) | 2/27/2020 - 3/8/2020 | 20.58% |
IGM Biosciences (IGMS) | 2/27/2020 - 3/8/2020 | 19.08% |
Phathom Pharmaceuticals (PHAT) | 2/27/2020 - 3/8/2020 | 18.62% |
Indivior PLC Ordinary Shares (INDV) | 2/27/2020 - 3/8/2020 | 18.55% |
Pacific Biosciences of California (PACB) | 2/27/2020 - 3/8/2020 | 17.91% |
AnaptysBio (ANAB) | 2/27/2020 - 3/8/2020 | 17.84% |
Savara (SVRA) | 2/27/2020 - 3/8/2020 | 17.57% |
SIGA Technologies (SIGA) | 2/27/2020 - 3/8/2020 | 15.37% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
